
JAMA study finds that 0.49% of Xarelto users had a major bleeding event during the first 3 months of treatment, compared to just 0.29% with Eliquis.
JAMA study finds that 0.49% of Xarelto users had a major bleeding event during the first 3 months of treatment, compared to just 0.29% with Eliquis.